Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 3
1986 1
1987 2
1988 6
1989 4
1990 5
1991 1
1992 3
1993 3
1994 8
1995 9
1996 8
1997 13
1998 9
1999 10
2000 4
2001 7
2003 5
2004 5
2005 4
2006 2
2007 6
2008 6
2009 8
2010 3
2011 5
2012 3
2013 2
2014 2
2015 6
2016 5
2018 2
2019 5
2020 2
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

169 results
Results by year
Filters applied: . Clear all
Page 1
Azelastine.
[No authors listed] [No authors listed] 2021 Sep 20. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006–. 2021 Sep 20. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006–. PMID: 30000120 Free Books & Documents. Review.
Small occasional doses of azelastine nasal spray would not be expected to cause any adverse effects in breastfed infants. ...The oral, nonsedating antihistamines are preferred alternatives. Because absorption from the eye is limited, azelastine would n …
Small occasional doses of azelastine nasal spray would not be expected to cause any adverse effects in breastfed infant …
OTC drugs for seasonal allergies.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2019 Apr 22;61(1570):57-60. Med Lett Drugs Ther. 2019. PMID: 31169808 No abstract available.
Second-generation antihistamines: a comparative review.
Slater JW, Zechnich AD, Haxby DG. Slater JW, et al. Drugs. 1999 Jan;57(1):31-47. doi: 10.2165/00003495-199957010-00004. Drugs. 1999. PMID: 9951950
Second-generation histamine H1 receptor antagonists (antihistamines) have been developed to reduce or eliminate the sedation and anticholinergic adverse effects that occur with older H1 receptor antagonists. This article evaluates second-generation antihistamines, i …
Second-generation histamine H1 receptor antagonists (antihistamines) have been developed to reduce or eliminate the sedation and anticholine …
Azelastine hydrochloride: a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability.
Bernstein JA. Bernstein JA. Curr Med Res Opin. 2007 Oct;23(10):2441-52. doi: 10.1185/030079907X226302. Curr Med Res Opin. 2007. PMID: 17723160 Review.
SCOPE: Searches of journal articles including the title word 'azelastine' from 1979 through the present were conducted by the product manufacturer primarily through Medline and EMBASE but also included, at various times, Dialog, Biosis, Toxline, and Diogenes (an adverse
SCOPE: Searches of journal articles including the title word 'azelastine' from 1979 through the present were conducted by the product …
Azelastine potentiates antiasthmatic dexamethasone effect on a murine asthma model.
Zappia CD, Soto A, Granja-Galeano G, Fenoy I, Fernandez N, Davio CA, Shayo C, Fitzsimons CP, Goldman A, Monczor F. Zappia CD, et al. Pharmacol Res Perspect. 2019 Oct 29;7(6):e00531. doi: 10.1002/prp2.531. eCollection 2019 Dec. Pharmacol Res Perspect. 2019. PMID: 31687162 Free PMC article.
Glucocorticoids are among the most effective drugs to treat asthma. However, the severe adverse effects associated generate the need for its therapeutic optimization. ...We used an allergen-induced model of asthma (employing ovalbumin) to evaluate the effects
Glucocorticoids are among the most effective drugs to treat asthma. However, the severe adverse effects associated generate th …
Azelastine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential.
McTavish D, Sorkin EM. McTavish D, et al. Drugs. 1989 Nov;38(5):778-800. doi: 10.2165/00003495-198938050-00005. Drugs. 1989. PMID: 2574665 Review.
The drug is superior to placebo and comparable to oral ketotifen 2 mg/day and sustained release theophylline 700 mg/day when administered as a twice daily oral 4 mg dose. Azelastine is generally well tolerated: the most common adverse effects are altered tast …
The drug is superior to placebo and comparable to oral ketotifen 2 mg/day and sustained release theophylline 700 mg/day when administered as …
Intranasal azelastine. A review of its efficacy in the management of allergic rhinitis.
McNeely W, Wiseman LR. McNeely W, et al. Drugs. 1998 Jul;56(1):91-114. doi: 10.2165/00003495-199856010-00011. Drugs. 1998. PMID: 9664202 Review.
The relative efficacies of azelastine and intranasal corticosteroids (beclomethasone and budesonide) remain unclear. ...The most frequently reported adverse events were bitter taste, application site irritation and rhinitis. ...
The relative efficacies of azelastine and intranasal corticosteroids (beclomethasone and budesonide) remain unclear. ...The most freq …
Treatment with azelastine hydrochloride and fluticasone propionate in a single delivery device of young children and adolescents with allergic rhinitis.
Berger WE, Mustakov TB, Kralimarkova TZ, Christoff G, Popov TA. Berger WE, et al. Allergy Asthma Proc. 2020 Jul 1;41(4):232-239. doi: 10.2500/aap.2020.41.200034. Allergy Asthma Proc. 2020. PMID: 32605694 Review.
Intranasal application of these medications has the advantage of a faster onset of action and avoids systemic unwanted adverse effects. The only combination treatment, which comprises azelastine hydrochloride and fluticasone propionate, so far in a single adv …
Intranasal application of these medications has the advantage of a faster onset of action and avoids systemic unwanted adverse eff
Efficacy and safety of azelastine 0.15% nasal spray and azelastine 0.10% nasal spray in patients with seasonal allergic rhinitis.
Shah S, Berger W, Lumry W, La Force C, Wheeler W, Sacks H. Shah S, et al. Allergy Asthma Proc. 2009 Nov-Dec;30(6):628-33. doi: 10.2500/aap.2009.30.3296. Epub 2009 Nov 19. Allergy Asthma Proc. 2009. PMID: 19930788 Clinical Trial.
Onset of action with azelastine 0.15% was within 30 minutes. Bitter taste was the most common adverse event with both azelastine 0.15% and azelastine 0.10% (8.4% and 9.4% of patients, respectively). Somnolence was reported by 1.7% of patients treated w …
Onset of action with azelastine 0.15% was within 30 minutes. Bitter taste was the most common adverse event with both azela
Efficacy and safety of azelastine nasal spray for the treatment of allergic rhinitis.
Golden SJ, Craig TJ. Golden SJ, et al. J Am Osteopath Assoc. 1999 Jul;99(7 Suppl):S7-12. doi: 10.7556/jaoa.1999.99.7.s7. J Am Osteopath Assoc. 1999. PMID: 10478514 Free article. Review.
The side effects of azelastine are drowsiness, headache, and bitter taste. ...Azelastine nasal spray seems to be an efficacious treatment for allergic rhinitis with a rapid onset and long duration of activity, but without the systemic adverse effect
The side effects of azelastine are drowsiness, headache, and bitter taste. ...Azelastine nasal spray seems to be an eff …
169 results